India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like Novotechnik introduces RFX 6900 Series of touchless rotary sensors January 29, 2018 The Year of Decentralization: Energy trends heading into 2019 February 7, 2019 How GIS Makes IoT Data Come Alive November 14, 2019